Biorasis Inc
BIORASIS has developed a biosensor aimed to revolutionize the way by which pre-clinical animal research is conducted for drug-development
- Stage Concept Only
- Industry Not Set
- Location Mansfield, CT, USA
- Currency USD
- Website bio-orasis.com
Company Summary
Biorasis is working towards the development of a miniaturized implantable continuous glucose sensor (CGM) for use in the pre-clinical animal research market. Due to its miniaturized size it is the only CGM that can be used in rodents, which are 98% of the animals used in research for drug-development. The savings from using our sensor as opposed to other technologies, is ca. 84% cost reduction for a 1 month research study.
Team
-
Ioannis TomazosChief Executive OfficerIoannis Tomazos, Ph.D., M.B.A. Since being appointed as the CEO of Biorasis Inc in 2008, Dr. Tomazos and his company have received numerous awards including the "Most Promising Life Sciences Company" in 2011 from the Connecticut Technology Council. He has served as the Principal Investigator for NIH and NSF SBIR grants, in addition to being a frequent panelist and
speaker in a number of meetings. He is currently working with his
company toward -
Fotios PapadimitrakopoulosVice President and Chairman of the BoardCurrently serving as Professor of Chemistry and Associate Director of the Institute of Materials Science at University of Connecticut, has over 15 years of experience in the areas of nano/bio-systems, supramolecular assembly of man-made artificial nanostructures and their unique interactions with biological entities (such as proteins, DNA and biocompatible polymers). Dr. Papadimitrakopoulos is a member of the Connecticut Academy of Science & Engi
-
Faquir JainVice PresidentCurrently serving as Professor of Electrical & Computer Engineering at the University of Connecticut, has over 35 years of experience in the areas design and fabrication of micro/opto-electronic devices and integrated circuits, multiple quantum-well light valves/modulators, acoustic-optic/electro-optic modulators, semiconductor lasers, opto-electronically triggered lasers, modeling, and transport in quantum wires and dots. Dr. Jain serves as the
-
Ioannis TomazosChief Executive OfficerIoannis Tomazos, Ph.D., M.B.A. Since being appointed as the CEO of Biorasis Inc in 2008, Dr. Tomazos and his company have received numerous awards including the "Most Promising Life Sciences Company" in 2011 from the Connecticut Technology Council. He has served as the Principal Investigator for NIH and NSF SBIR grants, in addition to being a frequent panelist and
speaker in a number of meetings. He is currently working with his
company toward -
Fotios PapadimitrakopoulosVice President & ChairmanCurrently serving as Professor of Chemistry and Associate Director of the Institute of Materials Science at University of Connecticut, has over 15 years of experience in the areas of nano/bio-systems, supramolecular assembly of man-made artificial nanostructures and their unique interactions with biological entities (such as proteins, DNA and biocompatible polymers). Dr. Papadimitrakopoulos is a member of the Connecticut Academy of Science & Engi
-
Faquir JainVice PresidentCurrently serving as Professor of Electrical & Computer Engineering at the University of Connecticut, has over 35 years of experience in the areas design and fabrication of micro/opto-electronic devices and integrated circuits, multiple quantum-well light valves/modulators, acoustic-optic/electro-optic modulators, semiconductor lasers, opto-electronically triggered lasers, modeling, and transport in quantum wires and dots. Dr. Jain serves as the
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.